Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Bunney, W. E. Articles by Akil, H. Search for Related Content PubMed Citation Articles by Bunney, W. E. Articles by Akil, H. Genetics Other Research Techniques

Microarray Technology: A Review of New Strategies to Discover Candidate Vulnerability Genes in Psychiatric Disorders

OBJECTIVE: An international effort is in progress to discover candidate genes and pathways associated with psychiatric disorders, including two of the most serious diseases, schizophrenia and mood disorders, through the use of new technology—microarrays. Instead of studying one gene at a time, microarrays provide the opportunity to analyze thousands of genes at once. METHOD: This article reviews the steps in this discovery process, including the acquisition and characterization of high-quality postmortem brain tissue, RNA extraction, and preparation and use of microarray technology. Two alternative microarray methods and factors affecting the quality of array data are reviewed. RESULTS: New analytical strategies are being developed to process the massive data sets generated by microarray studies and to define the significance of implicated genes. Array results must be validated by other methods, including in situ hybridization and real-time polymerase chain reaction. Identified genes can also be evaluated in terms of their chromosomal locations and possible overlap with regions of suggestive linkage or association identified with genome-wide linkage analysis in psychiatry and in terms of overlap with genes identified by microarray studies in animals administered psychoactive drugs. Microarray studies are only the first major step in the process. Further efforts in the investigation involve multiple strategies for studying function and gene structure, including transgenic and knockout animal studies. CONCLUSIONS: Microarrays present a methodology that can identify genes or pathways for new and unique potential drug targets, determine premorbid diagnosis, predict drug responsiveness for individual patients, and, eventually, initiate gene therapy and prevention strategies.

This article has been cited by other articles:

				K. D. Murray, P. V. Choudary, and E. G. Jones Nucleus- and cell-specific gene expression in monkey thalamus PNAS, February 6, 2007; 104(6): 1989 - 1994. [Abstract] [Full Text] [PDF]

				G. Coppola and D. H. Geschwind Microarrays and the microscope: balancing throughput with resolution J. Physiol., September 1, 2006; 575(2): 353 - 359. [Abstract] [Full Text] [PDF]

				K. Iwamoto and T. Kato Gene Expression Profiling in Schizophrenia and Related Mental Disorders Neuroscientist, August 1, 2006; 12(4): 349 - 361. [Abstract] [PDF]

				H. K. Gershenfeld, R. A. Philibert, and G. W. Boehm Looking Forward in Geriatric Anxiety and Depression: Implications of Basic Science for the Future Am J Geriatr Psychiatry, December 1, 2005; 13(12): 1027 - 1040. [Abstract] [Full Text] [PDF]

				P. V. Choudary, M. Molnar, S. J. Evans, H. Tomita, J.Z. Li, M. P. Vawter, R. M. Myers, W. E. Bunney Jr., H. Akil, S. J. Watson, et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression PNAS, October 25, 2005; 102(43): 15653 - 15658. [Abstract] [Full Text] [PDF]

				K. Iwamoto, M. Bundo, K. Yamada, H. Takao, Y. Iwayama-Shigeno, T. Yoshikawa, and T. Kato DNA Methylation Status of SOX10 Correlates with Its Downregulation and Oligodendrocyte Dysfunction in Schizophrenia J. Neurosci., June 1, 2005; 25(22): 5376 - 5381. [Abstract] [Full Text] [PDF]

				K E Wilson, M M Ryan, J E Prime, D P Pashby, P R Orange, G O'Beirne, J G Whateley, S Bahn, and C M Morris Functional genomics and proteomics: application in neurosciences J. Neurol. Neurosurg. Psychiatry, April 1, 2004; 75(4): 529 - 538. [Abstract] [Full Text] [PDF]

				J. Z. Li, M. P. Vawter, D. M. Walsh, H. Tomita, S. J. Evans, P. V. Choudary, J. F. Lopez, A. Avelar, V. Shokoohi, T. Chung, et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions Hum. Mol. Genet., March 15, 2004; 13(6): 609 - 616. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us